This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Euclid Systems Corporation Signs Agreement With Wenzhou Medical University To Promote The Use Of Orthokeratology To Control Myopia Progression

HERNDON, Va., Sept. 11, 2013 /PRNewswire/ -- Euclid Systems Corporation today announced the signing of a cooperation agreement with Wenzhou Medical University Eye Hospital. 

"Thanks to a number of studies showing the ability of Euclid's Emerald™ brand Ortho-K lens to retard the progression (worsening) of myopia in children, the Chinese population are accepting this treatment in increasing numbers," stated Michael A Ross, MD, President and COO of Euclid.  "This strategic partnership with the Wenzhou Medical University will further enhance Euclid's reputation as the leading provider of Ortho-K lenses in China and throughout Asia."

Through this cooperative agreement, Euclid will support and assist the University in several areas, including the training of new Optometrists and Ophthalmologists in the fitting and use of Orthokeratology lenses, as well as to study of the advantages of Orthokeratology for the prevention of the progression of myopia (nearsightedness) and for treatment for high myopes (extremely nearsighted) patients.  Wenzhou University will support Euclid by presenting at Ophthalmology meetings and conferences, by being a resource for prescribing doctors throughout China, and by promoting the health benefits and care standards for Orthokeratology.  Additionally the University will work with Euclid to open an Ortho-K Trial Center on the hospital grounds as a model for prescribing doctors in China.

About Wenzhou Medical University Eye Hospital.  The Affiliated Eye Hospital of Wenzhou Medical University is a class-A specialized eye hospital and is famous for its " Wenzhou Model" of combination of optometry and ophthalmology.  The eye hospital, the chairman unit of the Chinese Optometry Association, leads the development of optometry in China.  It is also the National Optometry Center of Ministry of Public Health P.R.China and the chairman unit of International Academy Orthokeratology Asia, playing a leading role in the training, discipline development, security monitoring and organization development of Orthokeratology in China.

About Euclid Systems Corporation.  Euclid, founded in 1995, first developed and brought to market a standardized Ortho-K lens design and manufacturing process.  Euclid was the first company to apply for FDA approval, and the Emerald lens was approved by the FDA in 2004.  The Emerald lens has obtained regulatory approval from the appropriate governing bodies in multiple international markets.  Additionally, Euclid is involved in a number of research projects investigating corneal stabilization.

SOURCE Euclid Systems Corporation

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,051.95 +11.58 0.06%
S&P 500 2,116.96 +5.23 0.25%
NASDAQ 5,097.0460 +14.1170 0.28%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs